# Geographic Atrophy Treatment Evaluation

> **NCT00890097** · PHASE3 · TERMINATED · sponsor: **Alcon Research** · enrollment: 772 (actual)

## Conditions studied

- Geographic Atrophy
- Age-Related Macular Degeneration

## Interventions

- **DRUG:** AL-8309B Ophthalmic Solution
- **DRUG:** AL-8309B Vehicle

## Key facts

- **NCT ID:** NCT00890097
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-04
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 772 (ACTUAL)
- **Why stopped:** Treatment ineffective
- **Last updated:** 2014-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00890097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00890097, "Geographic Atrophy Treatment Evaluation". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00890097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*